Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Diaceutics Share News (DXRX)
DXRX Share
Price
DXRX Share
News
DXRX Share
Chat
DXRX Share
Trades2
DXRX
Live RNS
DXRX Share
Charts
DXRX Level 2
Console
DXRX Live
Share Price
DXRX Broker
Ratings
DXRX Directors
Deals
DXRX Financial
Diary
DXRX
Fundamentals
DXRX Short
Positions
DXRX
Media
DXRX Company
Research
DXRX Company
Timeline
Diaceutics Information
Share Price Information for Diaceutics (DXRX)
Share Price is delayed by 15 minutes
Get Live Data
142.50
0.00 (0.00%)
Bid:
142.00
Ask:
143.00
Spread:
1.00 (0.704%)
Market Cap:
£120.60m
Last checked at -
Last checked at 
Intraday Diaceutics Share Chart
Diaceutics News
10 Dec 2021
TRADING UPDATES: Robinson warns on sales volumes; Wandisco wins deal
TRADING UPDATES: Robinson warns on sales volumes; Wandisco wins deal
14 Sep 2021
EARNINGS UPDATES: EKF Diagnostics very confident; Team17 sets records
EARNINGS UPDATES: EKF Diagnostics very confident; Team17 sets records
13 Sep 2021
TRADING UPDATES: Mobile Streams sees new launch, Toople wins contracts
TRADING UPDATES: Mobile Streams sees new launch, Toople wins contracts
8 Sep 2021
IN BRIEF: Diaceutics says two new experts join its advisory panel
IN BRIEF: Diaceutics says two new experts join its advisory panel
8 Jul 2021
TRADING UPDATES: Air Partner lifts forecast on private jet demand
TRADING UPDATES: Air Partner lifts forecast on private jet demand
8 Jul 2021
Diaceutics delivers 'strong start' to 2021 despite ongoing pandemic
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Thursday that it had delivered "a strong start to the 2021 financial year",...
24 Jun 2021
TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook
TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook
24 Jun 2021
Diaceutics secures multiple contracts with 'leading' pharma firms
(Sharecast News) - Diagnostics commercialisation company Diaceutics has secured four contracts with two "leading pharmaceutical companies" to solve re...
Follow the stocks
